The transcription factor GATA-1 recognizes a consensus motif present in regulatory regions of numerous erythroid-expressed genes. Mouse embryonic stem cells lacking GATA-1 cannot form mature red blood cells in vivo. In vitro differentiation of GATA-1-embryonic stem cells gives rise to a population of committed erythroid precursors that exhibit developmental arrest and death. We show here that the demise of GATA-1-erythroid cells is accompanied by several features characteristic of apoptosis. This process occurs despite normal expression of all known GATA target genes examined, including the erythropoietin receptor, and independent of detectable accumulation of the tumor suppressor protein p53. Thus, in addition to its established role in regulating genes that define the erythroid phenotype, GATA-1 also supports the viability of red cell precursors by suppressing apoptosis. These results illustrate the multifunctional nature of GATA-1 and suggest a mechanism by which other hematopoietic transcription factors may ensure the development of specific lineages.
The development of mature blood cells from pluripotent hematopoietic stem cells is controlled in part by lineagespecific transcription factors (1) . One such protein, the erythroid factor GATA-1, was initially identified as a zinc-fingercontaining nuclear protein that binds regulatory motifs [consensus (T/A)GATA(A/G)] in globin genes (reviewed in ref.
2). Subsequently, functionally important GATA-binding sites have been found in virtually all erythroid-specific genes (2, 3) . An essential role for GATA-1 in erythroid development has been established through gene knockout studies. Specifically, GATA-1-embryonic stem (ES) cells fail to produce mature erythroid cells in chimeric mice, although they contribute to the white cell lineages of blood as well as other tissues (4) .
To further define the block to erythropoiesis conferred by disruption of the GATA-1 gene, we recently utilized in vitro culture methods and demonstrated a complete block to (yolk sac-like) primitive erythropoiesis in the absence of GATA-1. In contrast, in vitro differentiation of GATA-1-ES cells gives rise to definitive erythroid colonies that initially appear normal but subsequently deteriorate due to developmental arrest and death of resident proerythroblasts (5) . Unexpectedly, GATA-1-erythroid cells express numerous GATA target genes at approximately normal levels immediately prior to their death. These include the erythropoietin (Epo) receptor, globins, glycophorin, the transferrin receptor, and the transcription factors erythroid Kruppel-like factor and stem cell leukemia (SCL, tal-1) (ref. 5 and unpublished data). Expression of these target genes in the absence of GATA-1 is most likely supported by the related transcription factor GATA-2, which is up-regulated about 50-fold in the mutant cells. Thus, GATA-1 is dispensable for erythroid lineage commitment and early development. Despite the ability of GATA-2 to partially compensate for the absence of GATA-1, mutant proerythroblasts are eventually rendered nonviable.
Hematopoietic cell homeostasis is controlled in part by regulation of apoptosis (6) (7) (8) , a morphologically distinct, cell-intrinsic form of death (9, 10) . We, therefore, sought to determine whether apoptosis contributes to the inability of GATA-1-erythroid cells to fully mature. We show here that GATA-1-proerythroblasts undergo apoptosis that is not accompanied by accumulation of the tumor suppressor protein, p53, a common effector of cell death. These results emphasize the multifunctional nature of GATA-1; in addition to regulating the expression of genes that distinguish the mature erythroid phenotype, it also acts as a survival factor for erythroid precursors.
MATERIALS AND METHODS
Cells. GATA-1-ES cell clones were derived from the wild-type line CCE (11) through targeted gene disruption of the GATA-1 gene (4). ES cells were maintained as described (5, 12) . W19 ts5 cells, U20S osteosarcoma cells that express the murine temperature-sensitive mutant, p53Val-135 (13) , were used as a positive control for p53 immunostaining. These cells were grown in Dulbecco's modified Eagle's medium with 10% fetal calf serum at 39°C. To induce nuclear accumulation of p53, cells were shifted to 32°C for 24 hr.
In Vitro Differentiation of ES Cells. Generation of pure erythroid colonies from ES cells was performed using the two-step in vitro differentiation method (12) . GATA-1-and wild-type definitive erythroid colonies were obtained by disaggregating 6-to 8-day-old embryoid bodies and replating into methylcellulose cultures containing Epo (2 units/ml) and kit ligand (stem cell factor; 50 ng/ml). For morphologic analysis, in situ apoptosis assays, and immunofluorescence, colonies were isolated from methycellulose cultures, resuspended in phosphate-buffered saline (PBS), and cytocentrifuged onto slides.
Electron Microscopy. Erythroid colonies were isolated from methylcellulose, resuspended in PBS, and centrifuged at 800 x g. The pellet was resuspended in 2.0% glutaraldehyde in 0.1 M sodium cacodylate buffer for 24 hr at 4°C. Cells were collected by centrifugation, postfixed in 1% osmium tetroxide, dehydrated in a graded series of alcohols, and embedded in epox 812. Ultrathin sections were cut on a Sorval MT 6000 microtome and examined in a Philips 300 electron microscope after staining with uranyl acetate and lead citrate.
In Situ Detection of Apoptosis. The TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling) (14) assay was performed using the ApoTag In Situ Abbreviations: ES, embryonic stem; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling; DAPI, 4',6-diamidino-2-phenylindole; Epo, erythropoietin; SCL, stem cell leukemia.
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Apoptosis Detection Kit (Oncor) according to the manufacturer's instructions.
Immunofluorescence. Cells were fixed in methanol/acetone (1:1) for 5 min, dried, and stained using the anti-p53 monoclonal antibody Ab-1 (Oncogene Science) at 10 ,ug/ml according to the manufacturer's instructions. Bound p53 antibody was detected using fluorescein-conjugated goat anti-mouse IgG (H+L) (Jackson ImmunoResearch) at 1.4 jig/ml. Cell nuclei were counterstained with 0.001% 4',6-diamidino-2-phenylindole (DAPI, HCl) for 5 min and then washed in PBS.
RESULTS
Erythroid colonies were generated in vitro from wild-type and GATA-1-ES cells. GATA-1-erythroid colonies are developmentally arrested and fail to hemoglobinize (Fig. 1 Left), consistent with our previous results (5). After 6 days in culture, the majority of cells within the mutant colonies die, whereas 95% of the cells within wild-type colonies remain viable, as measured by vital dye exclusion. For the following studies, we examined 5-day-old GATA-1-erythroid colonies, which typically contain about 50% viable cells. Cytological staining of mutant cells reveals arrest at the proerythroblast stage, in contrast to age-matched wild-type cells, which contain late pronormoblasts ( Fig. 1 Center). Many of the mutant cells contain fragmented nuclei with clumped chromatin, suggestive of apoptosis (9, 15) . Erythroid cells lacking GATA-1 stain intensely by the TUNEL method, which detects in situ endocolony nucleolytic cleavage characteristic of apoptosis (Fig. 1 Right) (14) .
Electron microscopy of dying GATA-1-erythroblasts reveals typical ultrastructural features of apoptosis: fragmented, homogeneously staining clumps of chromatin abutting the surface of the nuclear envelope (Fig. 2B) (9, 16, 17) . In contrast, the nucleus of normal cells remains intact and retains heterochromatin and euchromatin ( Fig. 2A) (18, 19) .
Thus, histological staining, the TUNEL assay, and electron microscopy indicate that GATA-1-erythroid precursors undergo apoptosis. The proportion of GATA-1-apoptotic cells detected by each method as well as cell viability measured by vital dye exclusion are in agreement (data not shown).
A normal characteristic of apoptosis is cell shrinkage (9, 16, 17 ), yet dying GATA-1-erythroblasts frequently appear larger than age-matched normal erythroid cells (Figs. 1 and 2 ). This apparent anomaly is most likely accounted for by the difference in maturation stage of mutant and wild-type cells. Reduction in cell size accompanies normal erythroid maturation. Thus, the normal cells appear smaller because they have continued to mature relative to mutant cells, which are developmentally arrested.
Stabilization and accumulation of the tumor suppressor protein p53 contribute to apoptosis in various circumstances, including expression of adenovirus 5 ElA protein in fibroblasts (20) , treatment of thymocytes with DNA-damaging agents (21, 22) , and forced expression of c-myc in serum-starved fibroblasts (23, 24) . We, therefore, investigated whether apoptosis cytology TUNEL in GATA-1 -erythroblasts is associated with accumulation of p53. Cells were stained with the nuclear dye DAPI (Fig. 3 Left) and, simultaneously, for p53 by immunofluorescence (Fig. 3 Right). Apoptotic nuclei (marked by the arrow, Fig. 3 Middle Left) are discernable in the mutant cells. In contrast to W19 ts5 cells, which were used as a positive control for immunostaining, no p53 was detected in either wild-type or dying GATA-1-erythroid cells, although equivalent, low levels of p53 mRNA are detectable by reverse transcription PCR in both cell types (unpublished data). These observations suggest that accumulation of p53 does not accompany apoptosis in GATA-1-erythroid cells but do not exclude the possibility that the process is dependent upon low levels of p53 that may be present in the dying cells.
DISCUSSION
We used in vitro differentiation of ES cells to more precisely define how GATA-1 acts to support erythroid development. GATA-1-ES cells give rise to normal numbers of erythroid colonies containing proerythroblasts that fail to mature properly and undergo apoptosis. Therefore, GATA-1 acts as a survival factor in terminally differentiated erythroid cells. The inability of GATA-1-ES cells to contribute to the mature definitive erythroid pool of chimeric mice (4) is probably due to rapid apoptosis and subsequent phagocytosis of the mutant proerythroblasts in hematopoietic tissues. In agreement with these observations, colony assays from yolk sac and fetal liver of chimeric mice demonstrate that GATA-1-ES cells give rise to definitive erythroid progenitors that fail to develop beyond the proerythroblast stage (25) . Our conclusions are also supported by recent observations that inhibition of GATA-1 function by an exogenously introduced estrogen receptor induces p53-independent apoptosis in murine erythroleukemia (MEL) cells (Gerd Blobel and S.H.O., unpublished data). In addition, erythroid lineage commitment, precursor proliferation, and expression of many GATA target genes occur in the absence of GATA-1. It is likely that some of these processes are sustained by the related protein GATA-2, which is derepressed in GATA-1-proerythroblasts (5).
Numerous erythroid-expressed GATA target genes have been linked to regulation of apoptosis, although none can adequately account for the demise of GATA-1-proerythroblasts. Erythropoietin regulates survival of late colonyforming units, erythroid, and proerythroblasts by preventing apoptosis (7, 19, 26, 27) . The generation of GATA-1-erythroid colonies is strictly Epo-dependent, and expression of the Epo receptor gene, which contains functional GATA motifs in its promoter and enhancer (28-30), appears to be unaffected in GATA-1-proerythroblasts (5) . These data demonstrate the presence of an intact Epo signaling pathway in the mutant cells and exclude the model that GATA-1 controls proerythroblast survival solely through transcriptional activation of the Epo receptor gene. The erythroid expressed presumptive GATA target gene SCL/tal-1 can suppress apoptosis in certain cell types under growth-limiting conditions (31) . However, SCL/ tal-1 mRNA level is normal in GATA-1-proerythroblasts (5). The cytosolic form of glutathione peroxidase (cGSHPX) expressed in erythroid cells functions to inactivate hydroperoxides, which can trigger apoptosis (32) . Although erythroid cGSHPX gene expression is regulated by GATA-binding sites in a 3' enhancer (33), cGSHPX mRNA levels are equivalent in wild-type and GATA-1-proerythroblasts (unpublished data). Finally, inhibition of heme synthesis in erythroid precursors can result in apoptosis (34) . The genes encoding the heme biosynthetic enzymes porphobilinogen deaminase (35, 36) and ferrochelatase (37) GATA-1 appears to negatively regulate GATA-2 during normal erythropoiesis (5) . It is possible that failure to repress GATA-2 may be involved in the death of proerythroblasts lacking GATA-1. GATA-2 normally is expressed in early erythroid precursors, where it may function to promote cellular proliferation (41), and is down-regulated as erythroid maturation proceeds (42) . Inappropriate expression of GATA-2, in proerythroblasts that are programed to stop dividing and terminally differentiate, may present conflicting growth signals that culminate in apoptosis, a precedent established by several cellular systems (43) .
It is apparent that GATA-1, an erythroid transcription factor initially identified by virtue of its ability to bind regulatory sequences in globin genes, has more pleotropic, fundamental roles in hematopoietic development. For example, enforced expression of GATA-1 influences lineage reprogramming in transformed cells (44, 45) , although in the studies DAPI Proc. Natl. Acad. Sci. USA 92 (1995) reported here and elsewhere (5), gene ablation of GATA-1 had no clear effect on lineage determination. Our data demonstrate that in addition to activating the expression of numerous genes associated with the mature erythroid phenotype, GATA-1 also acts as a survival factor by suppressing apoptosis in committed erythroid cells. Numerous hematopoietic transcription factors (reviewed in ref. 1) are required for generation of particular lineages and ultimately orchestrate the expression of genes within the specified cell types. We propose that enhancement of lineage survival through regulation of apoptosis may be a common mechanism by which transcription factors exert developmental control.
